Neuralink Starts Human Brain-Computer Trial
Neuralink, Elon Musk's brain-computer interface venture, is embarking on its groundbreaking human trial, recently greenlit by the FDA. The six-year "PRIME study" aims to test Neuralink's technology designed to assist individuals with paralysis, particularly those over 22 suffering from quadriplegia due to spinal cord injuries or ALS. Watch as we delve into the details of this pivotal trial, which explores the N1 implant, R1 surgical robot, and N1 user application, evaluating both safety and efficacy.
Although this trial falls short of Musk's ambitious telepathy and AI-human integration goals, it represents a significant step in the field of brain-computer interfaces, offering hope to many with limited mobility.
Despite controversies surrounding Neuralink's animal testing practices, the company moves forward, inviting participants to join an 18-month investigation with nine research visits, followed by five years of weekly research sessions. Neuralink will cover study-related expenses, though specific participant numbers and start dates remain undisclosed. Join us as we follow the PRIME study's progress, witnessing the potential transformation of human minds.
#Neuralink #ElonMusk #BrainComputerInterface #PRIMETrial #MedicalTechnology #ParalysisTreatment #Innovation #Healthcare #FDAApproval #Neuroscience #AIIntegration #ResearchStudy #Quadriplegia #SpinalCordInjury #ALS #MedicalResearch #ScientificAdvancements #NeuralinkTrial #MedicalBreakthrough